Worldwide: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process

All hospitals that are paid under the Medicare Outpatient Prospective Payment System and operate off-campus outpatient departments should prepare for submission of mandatory provider-based attestations (PBAs), even if they have submitted them in the past.

United States Healthcare

SR

McDermott Will & Schulte

Congress Probes Chinese Biotech GLP-1 Product Compliance

Although the FDA recently implemented additional safeguards related to imported GLP-1 products, the safety of GLP-1 active pharmaceutical ingredient ("API") remains a key congressional focus.

United States Healthcare

KM

Katten Muchin Rosenman LLP

Of Drugs And DTC Platforms: American Consumerism, TrumpRx, Telehealth, And The Specter Of Congressional Intervention

Debated is the genesis of the first direct-to-consumer drug concept in the U.S. Going back to at least 2011, Pfizer's "unorthodox" Diplomat Specialty Pharmacy partnership aimed to launch Lipitor DTC in the face of generic competition.

United States Healthcare

SM

Sheppard

NSCEB Paper Outlines Policy Options To Modernize Oversight Of Biotechnology Products

The National Security Commission on Emerging Biotechnology (NSCEB) has published a January 2026 discussion paper entitled "Creating Clear Regulatory Pathways for Biotechnology.

United States Healthcare

BC

Bergeson & Campbell

FDA Clinical Decision Support Software Guidance Refresh : Clearer Rules, Broader Innovation

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA's Draft Guidance For Cosmetics Industry Explains Records-Access Authority During Inspections

United States Healthcare

WR

Wiley Rein

District Court Certifies 23(b)(3) Class Action Alleging Injury From Misrepresentations That Pet Food Was "Healthy" Despite Presence Of PFAS

United States Healthcare

MG

Manko, Gold, Katcher & Fox

Health Headlines: January 2026

United States Healthcare

GP

Goodwin Procter LLP

FDA Seeks To Delay PFAS Litigation And Issues Report On PFAS In Cosmetics

United States Healthcare

D

Dechert

DOL Proposes Sweeping New Disclosure Rules For Pharmacy Benefit Managers

United States Employment

FL

Foley & Lardner

OIG Issues Special Advisory Bulletin On DTC Prescription Drug Sales To Federal Health Care Program Enrollees

United States Healthcare

AF

ArentFox Schiff

FDA Issues Report On PFAS In Cosmetics: Key Findings, Risks, And Regulatory Implications

United States Healthcare

AF

ArentFox Schiff

Preventative Care Test Garners Commercial Cost-Sharing Waiver Flexibility From OIG

United States Healthcare

BB

Bass, Berry & Sims

Food Venture Financing News – Weekly Issue No. 269

United States Commercial

DW

Davis Wright Tremaine

Food Venture Financing News – Weekly Issue No. 265

United States Healthcare

DW

Davis Wright Tremaine

Artificial Intelligence In ADR: A Neutral's Evolving Perspective

United States Technology

J

JAMS

Supreme Court Weighs Extent Of President's Authority To Impose Tariffs During Proclaimed National Emergencies

United States Litigation

D

Dykema

Simpson Thacher Sustainability And ESG: Regulatory Update – January 2026

Worldwide Environment

ST

Simpson Thacher & Bartlett

Back To School 2025: Title IX Updates And How ADR Can Help Universities Resolve Disputes (Podcast)

United States Litigation

J

JAMS

DOL Proposes Pharmacy Benefit Manager Fee Disclosure Rule

This is the first of several alerts that Groom Law Group expects to issue regarding the new proposed regulation issued on January 29, 2026 by the U.S. Department of Labor...

United States Employment

GL

Groom Law Group

3 Challenges And Opportunities For The Restaurant Industry In 2026

This year is bringing significant challenges for operators in the quick-service restaurant industry. Some may come as a surprise, and some are a continuation of the biggest hurdles...

United States Healthcare

GG

Greenberg Glusker Fields Claman & Machtinger

From The Locked Medicine Cabinet To Locker Rooms: The Sports Playbook For Medication Compliance; Assessing The Risks And Realities

Healthcare and medication compliance in the professional and collegiate sports industry sectors involves a myriad of federal and state requirements for physicians, clinical staff, and athletic trainers...

United States Healthcare

KM

Katten Muchin Rosenman LLP

DEA Extends Telemedicine Flexibilities For Controlled Substance Prescribing For 2026

The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit.

United States Healthcare

SR

McDermott Will & Schulte

Heads Up, Liquor Licensees: Kratom And 7-OH Could Put Your License At Risk

United States Healthcare

N

Nossaman LLP

DOJ Enforcement Branch Signals Strategic Shift In Civil Consumer And Policy Litigation

United States Consumer

MS

Miller Shah

Historic False Claims Act Enforcement Illustrates Trump Administration's Focus On Healthcare Fraud

United States Healthcare

GP

Goodwin Procter LLP

New Draft Guidance Addresses FDA's Records Access Authority For Cosmetics Under MoCRA

United States Healthcare

AF

ArentFox Schiff

Ohio Artificial Meat

United States Healthcare

SJ

Steptoe LLP

Outbreak Of New World Screwworm Highlights Importance Of Insect Sterilization Technique Technology And Regulation

United States Healthcare

BD

Beveridge & Diamond

SEC Enforcement Action Targets Insider Trading In The Pharmaceutical Industry

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

AI, Patents, And Precision Medicine: Highlights From Foley & Lardner's 2026 Health Care & Life Sciences Trends Report

United States Technology

FL

Foley & Lardner

SEC Enforcement Action Against Former Spero Executives: Individual Liability For Misleading FDA-Related Disclosures

United States Commercial

FL

Foley & Lardner

OEHHA's Prop 65 "Fact Sheet" Needs A 2026 Update

United States Environment

SJ

Steptoe LLP

SEC Enforcement Action Targets Insider Trading In The Pharmaceutical Industry

On December 22, 2025, the U.S. Securities and Exchange Commission (SEC) filed a complaint against several defendants for their roles in market manipulation schemes involving two pharmaceutical companies, Olema Pharmaceuticals, Inc. (Olema) and Opiant Pharmaceuticals, Inc. (Opiant).

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

AI, Patents, And Precision Medicine: Highlights From Foley & Lardner's 2026 Health Care & Life Sciences Trends Report

The health care and life sciences sector is entering a period of accelerated transformation shaped by new technologies, shifting regulatory frameworks, and evolving market demands.

United States Technology

FL

Foley & Lardner

SEC Enforcement Action Against Former Spero Executives: Individual Liability For Misleading FDA-Related Disclosures

On January 16, 2026, the Securities and Exchange Commission (SEC) instituted settled cease‑and‑desist proceedings against Ankit Mahadevia and Satyavrat Shukla...

United States Commercial

FL

Foley & Lardner

OEHHA's Prop 65 "Fact Sheet" Needs A 2026 Update

The agency that promulgates the regulations governing Proposition 65 — the Office of Environmental Health Hazard Assessment (OEHHA) — provides to the public a "Fact Sheet"...

United States Environment

SJ

Steptoe LLP

Self‑Collection Kits In The Crosshairs

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Holland & Knight Health Dose: January 27, 2026

Passage of a multi-bill appropriations package now looks to potentially be in jeopardy, following events over the weekend in Minneapolis. U.S. Senate Minority Leader Chuck Schumer (D-N.Y.) issued a statement...

United States Healthcare

HK

Holland & Knight

House Judiciary Committee Report Alleges Anticompetitive PBM Conduct Targeting Pharmacy Hubs

On January 22, 2026, the U.S. House Judiciary Committee's Antitrust Subcommittee staff released an interim report concluding that CVS Health and its pharmacy benefit manager (PBM) subsidiary...

United States Anti-trust

DM

Duane Morris LLP

False Claims Act Recoveries Reach Record $6.8 Billion In Fiscal Year 2025

The United States Department of Justice ("DOJ") reports record-setting False Claims Act ("FCA") recoveries reflecting the administration's continued use of the statute.

United States Healthcare

JD

Jones Day

Digital Health Policy: FDA Relaxes Restrictions Over Wearables And AI Decision Making Tools In Two New 2026 Guidances

On January 6, 2026, the U.S. Food & Drug Administration updated two guidance documents, General Wellness: Policy for Low Risk Devices and Clinical Decision Support Software, addressing digital health technologies such as wearables and AI "chatbots."

United States Healthcare

FL

Foley & Lardner

Can AI-Discovered Drugs Be Patented? (Podcast)

United States IP

GP

Goodwin Procter LLP

Protein Bars, Market Definition And Injunctions

United States Anti-trust

BP

Bona Law PC

Marijuana Rescheduling: Should Employers Update Their Drug Testing Policies And Practices?

United States Cannabis

SS

Seyfarth Shaw LLP

FDA Issues Report On PFAS In Cosmetics Products

United States Healthcare

HK

Holland & Knight

French Insider Episode 43: The Evolving U.S. Wine Industry: Trends, Global Context And The Road Ahead With Jean Hoefliger (Podcast)

United States Healthcare

SM

Sheppard

Strategic Defenses And The "Silence Option" In The CY 2026 OPPS Drug Cost Survey

United States Healthcare

SR

McDermott Will & Schulte

FDA Takes Action To Improve Gluten Ingredient Disclosure In Foods

United States Healthcare

DT

Diaz Trade Law

U.S. Supreme Court Rules State Affidavit/Certificate Of Merit Requirements Do Not Apply In Federal Court

United States Litigation

DM

Duane Morris LLP

NMED Posts Revised Proposed PFAS Reporting, Labeling, And Prohibition Rule

United States Environment

BC

Bergeson & Campbell

Where Healthcare Exits Are Heading In 2026

United States Healthcare

SR

McDermott Will & Schulte

Absent Congressional Action, Most Laboratories Required To Submit Outdated Data To CMS Beginning February 1, 2026

United States Healthcare

BB

Bass, Berry & Sims

DOJ's FY 2025 FCA Numbers Send A Clear Message: Enforcement Risk Is Rising

United States Healthcare

AP

Arnold & Porter

Food Venture Financing News – Weekly Issue No. 268

United States Healthcare

DW

Davis Wright Tremaine

2026 Extension Of Telemedicine Prescribing Flexibilities: Impacts On Patients And Providers

United States Healthcare

SM

Sheppard

New Federal Nutrition Guidelines Signal Continued Scrutiny Of Ultra-Processed Foods

United States Healthcare

WR

Wiley Rein

See more

Highlighted Content

The Nexus Of Trade And Food Security Amid Global Conflicts

United States International

BG

Braumiller Law Group, PLLC

Any Comments On FDA's New Proposed Rule On Prior Notice Regulations?

United States International

BG

Braumiller Law Group, PLLC

World Trade And Invasion, One Year Later – Are We On The Brink Of A New World Order?

United States International

BG

Braumiller Law Group, PLLC

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

Latest Videos

See more

The Exploration Crisis: Why Oil & Gas Companies Are Finding Less While Demand Keeps Growing (Video)

AM

Alvarez & Marsal

Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)

RG

Ropes & Gray LLP

Live From Workplace Horizons 2025: What's Hot In ERISA — Forfeiture And Tobacco Surcharge Class Actions (Video)

JL

Jackson Lewis P.C.

Concerns For Employers Surrounding Employee Drug And Alcohol Testing Policies (Video)

FS

Foster Swift Collins & Smith

Food And Consumer Product Litigation And Regulatory Update: Webinar Replay (Video)

ML

McGuireWoods LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More